Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.2M Buy
22,290
+2,443
+12% +$3.89M 0.18% 108
2026
Q1
$26.1M Buy
19,847
+664
+3% +$910K 0.13% 146
2025
Q4
$20.5M Buy
19,183
+1,769
+10% +$1.85M 0.11% 171
2025
Q3
$16.7M Buy
17,414
+1,653
+10% +$1.3M 0.11% 181
2025
Q2
$12.6M Buy
15,761
+2,958
+23% +$2.12M 0.1% 203
2025
Q1
$8.63M Buy
12,803
+2,899
+29% +$2.11M 0.09% 213
2024
Q4
$7.04M Buy
9,904
+2,729
+38% +$1.96M 0.08% 229
2024
Q3
$5.98M Buy
7,175
+4,308
+150% +$3.85M 0.12% 179
2024
Q2
$2.93M Buy
2,867
+1,668
+139% +$1.6M 0.13% 166
2024
Q1
$1.16M Buy
+1,199
New +$1.06M 0.16% 133

Other funds holding ASML

&Partners's ASML Position: Q2 2026 in Review

&Partners increased its ASML (ASML) stake by 12% in Q2 2026, buying an estimated $3.89M and bringing the position to 22,290 shares worth $44.2M. The position accounts for 0.18% of the portfolio, ranked #108.

&Partners first reported a position in ASML in Q1 2024 and has held it in 10 quarters since. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • &Partners held 22,290 shares of ASML worth $44.2M as of Q2 2026.
  • &Partners bought 2,443 ASML shares in Q2 2026, an estimated $3.89M.
  • ASML made up 0.18% of &Partners's portfolio in Q2 2026, its #108 holding.
  • &Partners first reported a position in ASML in Q1 2024 and has held it in 10 quarters since.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.